Cognitive Considerations in OAB: Combining Communication and Treatment Strategies for Better Patient Outcomes

Target Audience

This educational activity is intended for urologists, urogynecologists, physician assistants, nurse practitioners, nurses, and other clinicians caring for patients with overactive bladder.

Learning Objectives

After completing this activity, participants will be better able to:

  • Review the data on central nervous system effects of antimuscarinic overactive bladder medications with those of β3-adrenoceptor agonists
  • Apply communication strategies on managing overactive bladder to improve the patient-clinician partnership
  • Review clinical trial data on new treatments for overactive bladder
  • Develop appropriate treatment strategies for patients with overactive bladder
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Course opens: 
10/31/2022
Course expires: 
01/31/2023
Cost:
$0.00

Faculty

Una J. Lee, MD, FPMRS (Chair)
Urology Physician Lead
Virginia Mason Franciscan Health
Associate Program Director, Female Pelvic Medicine and Reconstructive Surgery Fellowship
Virginia Mason Medical Center
Associate Clinical Professor of Urology
University of Washington
Seattle, Washington
Ekene Enemchukwu, MD, MPH, FACS, FPMRS
Assistant Professor of Urology
Assistant Professor of Obstetrics and Gynecology (Urogynecology), by Courtesy
Medical Director, Stanford Multidisciplinary Pelvic Health Center
Female Pelvic Medicine and Reconstructive Surgery
Male Voiding Dysfunction and Neurourology
Stanford University School of Medicine
Palo Alto, California

Disclosure Policy

MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.

Faculty

Ekene Enemchukwu, MD, MPH,  is a consultant for AbbVie Inc*, Avation Medical*, Boston Scientific, and Urovant Sciences Inc*; and is a contracted researcher for AbbVie Inc, Avation Medical*, Urovant Sciences Inc.

Una J. Lee, MD, is a consultant for Axonics, Inc, Laborie, and Medtronic; and is a contracted researcher for Cook MyoSite and Medtronic.

* The financial relationship existed during the last 24 months but has now ended.

Peer Reviewer

This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.

Planners, Managers, and Writers

MedEdicus planners, managers, and writers have no relevant commercial relationships to disclose.

For Physicians

ACCME Accreditation Statement

 MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Credit Designation Statement

MedEdicus LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses

Interprofessional Joint Accreditation Statement

image In support of improving patient care, this activity has been planned and implemented by MedEdicus LLC and Amedco LLC. Amedco LLC is jointly accredited by the ACCME, the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nurses (ANCC) Credit Designation

Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.

Disclosure of Commercial Support

This continuing medical education activity is supported through an educational grant from Urovant Sciences, Inc.

Off-Label Discussion

This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.

Americans With Disabilities Act

MedEdicus fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please contact info@mededicus.com with any special needs (eg, physical, dietary) prior to the program.

Provider Contact Information

For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.

Fee Information

There is no fee for this educational activity.

Disclaimer

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC, Amedco LLC, or Urovant Sciences, Inc.

This CME/CE activity is copyrighted to MedEdicus LLC ©2022. All rights reserved. 284

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Click Take course to proceed to the evaluation and to obtain your certificate.